One Eyebrow Higher After Muscle Relaxing Treatment: How to Address It?

One eyebrow sitting noticeably higher than the other. The arched, almost theatrical look practitioners call the Mephisto brow. A brow that feels heavier and lower after treatment than it did before.

These are among the most common concerns patients bring to me, and I say that with no judgment. What I want to say is this: they are almost entirely preventable. When they do occur, they are almost always correctable. And understanding why they happen is the single most important thing a patient can know before booking any anti-wrinkle treatment.

When I was a cardiac nurse at KIMS Hospital, I spent years understanding the balance between opposing muscle groups: the forces that open and close valves, the mechanisms that maintain equilibrium in complex biological systems. Your brow is a simpler system, but the principle is identical. Two sets of opposing muscles. A precise equilibrium. Introduce any variable unevenly, and the balance shifts. Botulinum toxin does not fail unpredictably. When asymmetry occurs, there is always a reason. And that reason is almost always anatomical.

The muscle system your brow depends on

Your eyebrow position is not fixed. It is maintained moment to moment by two muscle groups working constantly against each other. Research published in PMC describes this precisely: brow position is determined by the balance between the upward pull of the frontalis and the downward pull of the depressor complex.

The frontalis is the broad, flat muscle running across your forehead. It is the only muscle that lifts your brows. It has no opposing elevator. Relax it too much, or unevenly from side to side, and the brow drops. There is nothing to compensate.

Below it sits the depressor complex: the corrugator supercilii pulling the brow medially and creating frown lines between the brows, the procerus pulling the nasal bridge and medial brow downward, the depressor supercilii depressing the medial brow, and the orbicularis oculi, the large circular muscle surrounding the eye whose upper fibres contribute to brow depression. Treat these depressors and the brow lifts, because the frontalis is no longer opposed by the same downward force and rises to a new equilibrium. This is entirely intentional in a chemical brow lift. The problem arises when the system is treated unevenly, without individual assessment, or without accounting for what already exists in a patient's anatomy before a single injection is placed.

Why asymmetry happens

There are four mechanisms, and understanding them matters because it helps patients evaluate the quality of care they are receiving.

Uneven depressor treatment is the most common cause. If more toxin is placed on the depressors of one side than the other, that side experiences less downward pull. The frontalis on that side lifts the brow higher. Studies measuring brow position confirm that a difference of just 2mm is consistently noticeable to patients. That is a clinically small margin with a clinically significant visual consequence.

Uneven frontalis dosing produces the opposite problem. If one side of the frontalis is weakened more than the other, that brow drops. The sole elevator on that side is partially neutralised with nothing to compensate. Even a subtle difference in dose or placement can produce visible asymmetry within the millimetre range patients detect.

Pre-existing asymmetry that was not measured before treatment is the cause most patients do not expect. A study of 683 patients measuring brow position before treatment found that significant brow height asymmetry is common before any toxin is introduced. Treating an asymmetrical face identically does not create symmetry. In many cases, it exaggerates what was already there. A practitioner who does not assess and document natural asymmetry before treating is introducing a variable they have not controlled and will not be able to explain when the patient returns at two weeks.

Finally, differences in underlying muscle strength. The same dose does not produce the same effect in every patient, or even in the two sides of the same face. Muscle mass, tone, and habitual pattern of use vary from person to person and side to side. Adjusting for this requires individual assessment, not a standard template applied bilaterally.

The Mephisto brow

The Mephisto brow, sometimes called the Spock brow, is an exaggerated lateral brow elevation giving the brows a pointed, arched, or theatrical appearance, named after the operatic character whose raised outer brow conveys suspicion. It happens when the central frontalis is treated adequately but the lateral fibres remain active. The lateral brow then elevates independently, without the counterbalance of central movement. The result is a brow shape that looks unnatural precisely because it does not correspond to any genuine emotional expression.

This is not a mysterious complication. It is a direct consequence of inadequate lateral frontalis treatment, and it is correctable with a small, precisely placed additional dose to the elevated lateral area.

How asymmetry is corrected

The correction approach depends entirely on which mechanism created the asymmetry, which is why assessment before any correction is as important as the correction itself.

When one brow sits too high due to uneven depressor treatment, a small targeted dose to the frontalis on the elevated side reduces its lift. When the Mephisto brow is present, a small lateral frontalis adjustment restores balance within five to seven days. When one brow has dropped because the frontalis was over-treated, the honest answer is to wait. The toxin wears off over three to four months and the brow returns. Attempting to inject around an over-treated frontalis carries more risk than benefit.

For significant pre-existing asymmetry that was not addressed at initial treatment, the most reliable approach is a full bilateral reassessment. A clinical study of 115 patients found that bilateral symmetric chemodenervation of both depressors and frontalis achieved symmetry of 0 to 1mm in 72% of patients. The mechanism is logical: resetting both the lifting and pulling forces to a new balanced equilibrium resolves asymmetry from first principles rather than chasing it reactively.

What prevention actually looks like

Before any treatment at Juvenology, both brows are assessed, measured, and photographed. The injection plan reflects what is actually there. Pre-existing asymmetry requires deliberate asymmetric treatment to produce a symmetric result. The frontalis-procerus interdigitation point, where over-treatment most commonly produces medial brow drop, is treated with particular precision. The mandatory two-week review is included as a clinical expectation, not a formality: at two weeks the toxin has reached full effect and any asymmetry is visible while the treatment window is still open.

As StatPearls confirms, selective chemodenervation allows for targeted correction, but it requires thorough pre-treatment assessment and individual anatomy evaluation as its foundation. Any practitioner offering forehead anti-wrinkle treatment should be able to measure your brows before placing a single unit, discuss any natural asymmetry you already have, and explain the dosing rationale for each side specifically. If none of that happens, the assessment is incomplete.

About Me

I’m Nurse Marina, founder of Juvenology Clinic in Maidstone, Kent. I’ve been a nurse for 25 years, which probably explains why I’m obsessed with precision, safety, and understanding how the body works.

I’m an NMC Registered nurse, JCCP Verified, a BACN Member, ACE Group Registered, a member of the Royal College of Nursing, and recognised by the Professional Standards Authority.

If you want to see more of what I do day to day, I share education, clinic insights, and the occasional behind-the-scenes moment here.

Instagram: https://www.instagram.com/juvenologyclinic/

TikTok: https://www.tiktok.com/@juvenologyclinic